ARCHIVES

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

This article is from The Cancer Letter archive.

Vol. 39 No. 42 | November 8, 2013

Download PDF Visit The Full Archive

Related Articles

Pancreatic Cancer Research To Increase, Institute Says.

November 16, 2001

To nurture staff, NCI plans an academy.

February 13, 2004

Mihich Recommendation for Antigen Development In BRMP Summarized

December 14, 1979

New Health Bills Could Affect Cancer Program

February 9, 1979

Mass. Public Health Commissioner Koh Named To NCAB; Kovach To Direct Long Island Center.

October 27, 2000

In Brief: Doug Ulman named CEO of Pelotonia

September 26, 2014